Drugs / FMP014
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1 | NCT04296279 Comparator | Mar 2020 → Dec 2021 | vaccinia | U.S. Army Medical Research and Development Command | Unknown | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FMP014 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04296279 ↗ |
| Known as | Plasmodium falciparum Malaria Protein 014 | “Plasmodium falciparum Malaria Protein 014 (FMP014)” NCT04296279 ↗ |
| Route | Intramuscular | “Administered Via Intramuscular Injection” NCT04296279 ↗ |